- Home
- LSTA vs CXAI Comparison
LSTA vs CXAI Comparison
Compare LSTA & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- CXAI
- Stock Information
- Founded
- LSTA 1980
- CXAI N/A
- Country
- LSTA United States
- CXAI United States
- Employees
- LSTA N/A
- CXAI N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- CXAI EDP Services
- Sector
- LSTA Health Care
- CXAI Technology
- Exchange
- LSTA Nasdaq
- CXAI Nasdaq
- Market Cap
- LSTA 20.9M
- CXAI 22.4M
- IPO Year
- LSTA N/A
- CXAI N/A
- Fundamental
- Price
- LSTA $2.73
- CXAI $1.03
- Analyst Decision
- LSTA Strong Buy
- CXAI
- Analyst Count
- LSTA 1
- CXAI 0
- Target Price
- LSTA $15.00
- CXAI N/A
- AVG Volume (30 Days)
- LSTA 15.4K
- CXAI 458.8K
- Earning Date
- LSTA 08-11-2025
- CXAI 08-11-2025
- Dividend Yield
- LSTA N/A
- CXAI N/A
- EPS Growth
- LSTA N/A
- CXAI N/A
- EPS
- LSTA N/A
- CXAI N/A
- Revenue
- LSTA $1,000,000.00
- CXAI $6,548,000.00
- Revenue This Year
- LSTA N/A
- CXAI N/A
- Revenue Next Year
- LSTA N/A
- CXAI $60.00
- P/E Ratio
- LSTA N/A
- CXAI N/A
- Revenue Growth
- LSTA N/A
- CXAI N/A
- 52 Week Low
- LSTA $1.87
- CXAI $0.76
- 52 Week High
- LSTA $4.20
- CXAI $3.76
- Technical
- Relative Strength Index (RSI)
- LSTA 54.95
- CXAI 52.72
- Support Level
- LSTA $2.36
- CXAI $0.99
- Resistance Level
- LSTA $3.07
- CXAI $1.11
- Average True Range (ATR)
- LSTA 0.22
- CXAI 0.06
- MACD
- LSTA 0.03
- CXAI 0.02
- Stochastic Oscillator
- LSTA 52.78
- CXAI 66.10
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.